![Christopher Baldwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Baldwin
Corporate Officer/Principal bij
BCAL DIAGNOSTICS LIMITED
Profiel
Christopher Baldwin is currently Chief Commercial Officer at BCAL Diagnostics Ltd. Formerly, Dr. Baldwin was Chief Commercial Officer & Deputy CEO at Exopharm Ltd. from 2021 to 2022 and Executive Director at New York Blood Center, Inc. Education includes a doctorate from Trinity College.
Actieve functies van Christopher Baldwin
| Bedrijven | Functie | Begin |
|---|---|---|
| BCAL DIAGNOSTICS LIMITED | Corporate Officer/Principal | - |
Eerdere bekende functies van Christopher Baldwin
| Bedrijven | Functie | Einde |
|---|---|---|
| EXOPHARM | Corporate Officer/Principal | 01-02-2022 |
New York Blood Center, Inc.
 New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Directeur/Bestuurslid | - |
Opleiding van Christopher Baldwin
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
18
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
New York Blood Center, Inc.
New York Blood Center, Inc. Medical/Nursing ServicesHealth Services Operates as blood collection and distribution organization | Health Services |
Trinity College
 Trinity College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BCAL Diagnostics Ltd.
 BCAL Diagnostics Ltd. Medical/Nursing ServicesHealth Services Engages in medical research and testing services | Health Services |
Exopharm Ltd.
 Exopharm Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of exosomes as therapeutic agent | Health Technology |
